48 - Preclinical Testing Part 3: Alzheimer's Disease August 2020

Join Anusha as she dives into papers published from August of 2020 that uncovers the effects of potential therapeutics in animal models for Alzheimer's Disease. In the first section, she covers research that targets multiple aspects of Alzheimer's pathology. In the second section, she focuses on research that aims to improve cognition and memory in animal models. 

------------------------------------------------------------------ 

To receive the list of papers covered, please fill this form:  

-------->  https://forms.gle/CVVbznAFM8pamdgk6  -------  

or by tweeting at us: @AMiNDR_podcast  

------------------------------------------------------------------ 

We would appreciate your feedback so we can better cater to your needs.  

You can fill our feedback form here  

---------->  https://forms.gle/5aq2JyrT6g4P1m8v6 

You can also share your thoughts and suggestions by contacting us:  

Email: [email protected]  

Facebook:  AMiNDR  

Twitter: @AMiNDR_podcast

Instagram: @AMiNDR.podcast

------------------------------------------------------------------ 

Today's episode was scripted and edited by Anusha Kamesh, and made possible by an entire team of volunteers behind the scenes.  

Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic.  

https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w  

------------------------------------------------------------------ 

If you are interested in joining the team, send us your CV by email. We are specifically looking for help with abstract summary and podcast editing. However, if you are interested in helping in other ways, don't hesitate to apply anyways.  

------------------------------------------------------------------ 

*About AMiNDR: *  

Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!"